Publications
Found 19 results
Filters: Author is Lahoutte, Tony [Clear All Filters]
"Sortase A-mediated site-specific labeling of camelid single-domain antibody-fragments: a versatile strategy for multiple molecular imaging modalities.",
Contrast Media Mol Imaging, vol. 11, issue 5, pp. 328-339, 2016 09.
"Monitoring liver macrophages using nanobodies targeting Vsig4: Concanavalin A induced acute hepatitis as paradigm.",
Immunobiology, vol. 220, issue 2, pp. 200-9, 2015 Feb.
"Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer.",
Contrast Media Mol Imaging, vol. 9, issue 3, pp. 211-20, 2014 May-Jun.
"Molecular imaging with macrophage CRIg-targeting nanobodies for early and preclinical diagnosis in a mouse model of rheumatoid arthritis.",
J Nucl Med, vol. 55, issue 5, pp. 824-9, 2014 May.
"Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer.",
Expert Opin Drug Deliv, vol. 11, issue 12, pp. 1939-54, 2014 Dec.
"Site-specific labeling of cysteine-tagged camelid single-domain antibody-fragments for use in molecular imaging.",
Bioconjug Chem, vol. 25, issue 5, pp. 979-88, 2014 May 21.
"Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1.",
Mol Imaging Biol, vol. 16, issue 5, pp. 690-8, 2014 Oct.
"Targeted radionuclide therapy with A 177Lu-labeled anti-HER2 nanobody.",
Theranostics, vol. 4, issue 7, pp. 708-20, 2014.
"Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target.",
Expert Opin Biol Ther, vol. 13, issue 8, pp. 1149-60, 2013 Aug.
"Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer.",
J Nucl Med, vol. 54, issue 5, pp. 776-84, 2013 May.
"Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators.",
Contrast Media Mol Imaging, vol. 7, issue 2, pp. 254-64, 2012 Mar-Apr.
"Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions.",
Circ Res, vol. 110, issue 7, pp. 927-37, 2012 Mar 30.
"Nanobody-coupled microbubbles as novel molecular tracer.",
J Control Release, vol. 158, issue 2, pp. 346-53, 2012 Mar 10.
"Pre-clinical studies of toxin-specific nanobodies: evidence of in vivo efficacy to prevent fatal disturbances provoked by scorpion envenoming.",
Toxicol Appl Pharmacol, vol. 264, issue 2, pp. 222-31, 2012 Oct 15.
"Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy.",
Mol Imaging Biol, vol. 13, issue 5, pp. 940-8, 2011 Oct.
"Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice.",
Contrast Media Mol Imaging, vol. 6, issue 2, pp. 85-92, 2011 Mar-Apr.
"Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer.",
FASEB J, vol. 25, issue 7, pp. 2433-46, 2011 Jul.
"In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT.",
J Nucl Med, vol. 51, issue 7, pp. 1099-106, 2010 Jul.
"Nanobodies as tools for in vivo imaging of specific immune cell types.",
J Nucl Med, vol. 51, issue 5, pp. 782-9, 2010 May.